Global Panitumumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 13-Sep-2019
No. of pages: 100

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).

Scope of the Report:

The global Panitumumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Panitumumab.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Panitumumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Panitumumab market by product type and applications/end industries.

Market Segment by Companies, this report covers

- Amgen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- 100 mg/5 mL single-dose vials

- 400 mg/20 mLsingle-dose vials

Market Segment by Applications, can be divided into

- Hospital

- Drug store

Global Panitumumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Panitumumab Market Overview
1.1 Product Overview and Scope of Panitumumab
1.2 Classification of Panitumumab by Types
1.2.1 Global Panitumumab Revenue Comparison by Types (2019-2024)
1.2.2 Global Panitumumab Revenue Market Share by Types in 2018
1.2.3 100 mg/5 mL single-dose vials
1.2.4 400 mg/20 mLsingle-dose vials
1.3 Global Panitumumab Market by Application
1.3.1 Global Panitumumab Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Panitumumab Market by Regions
1.4.1 Global Panitumumab Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Panitumumab Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Panitumumab Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Panitumumab Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Panitumumab Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Panitumumab Status and Prospect (2014-2024)
1.5 Global Market Size of Panitumumab (2014-2024)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Panitumumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Panitumumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Panitumumab Market Competition, by Players
3.1 Global Panitumumab Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Panitumumab Players Market Share
3.2.2 Top 10 Panitumumab Players Market Share
3.3 Market Competition Trend
4 Global Panitumumab Market Size by Regions
4.1 Global Panitumumab Revenue and Market Share by Regions
4.2 North America Panitumumab Revenue and Growth Rate (2014-2019)
4.3 Europe Panitumumab Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Panitumumab Revenue and Growth Rate (2014-2019)
4.5 South America Panitumumab Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Panitumumab Revenue and Growth Rate (2014-2019)
5 North America Panitumumab Revenue by Countries
5.1 North America Panitumumab Revenue by Countries (2014-2019)
5.2 USA Panitumumab Revenue and Growth Rate (2014-2019)
5.3 Canada Panitumumab Revenue and Growth Rate (2014-2019)
5.4 Mexico Panitumumab Revenue and Growth Rate (2014-2019)
6 Europe Panitumumab Revenue by Countries
6.1 Europe Panitumumab Revenue by Countries (2014-2019)
6.2 Germany Panitumumab Revenue and Growth Rate (2014-2019)
6.3 UK Panitumumab Revenue and Growth Rate (2014-2019)
6.4 France Panitumumab Revenue and Growth Rate (2014-2019)
6.5 Russia Panitumumab Revenue and Growth Rate (2014-2019)
6.6 Italy Panitumumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Panitumumab Revenue by Countries
7.1 Asia-Pacific Panitumumab Revenue by Countries (2014-2019)
7.2 China Panitumumab Revenue and Growth Rate (2014-2019)
7.3 Japan Panitumumab Revenue and Growth Rate (2014-2019)
7.4 Korea Panitumumab Revenue and Growth Rate (2014-2019)
7.5 India Panitumumab Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Panitumumab Revenue and Growth Rate (2014-2019)
8 South America Panitumumab Revenue by Countries
8.1 South America Panitumumab Revenue by Countries (2014-2019)
8.2 Brazil Panitumumab Revenue and Growth Rate (2014-2019)
8.3 Argentina Panitumumab Revenue and Growth Rate (2014-2019)
8.4 Colombia Panitumumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Panitumumab by Countries
9.1 Middle East and Africa Panitumumab Revenue by Countries (2014-2019)
9.2 Saudi Arabia Panitumumab Revenue and Growth Rate (2014-2019)
9.3 UAE Panitumumab Revenue and Growth Rate (2014-2019)
9.4 Egypt Panitumumab Revenue and Growth Rate (2014-2019)
9.5 Nigeria Panitumumab Revenue and Growth Rate (2014-2019)
9.6 South Africa Panitumumab Revenue and Growth Rate (2014-2019)
10 Global Panitumumab Market Segment by Type
10.1 Global Panitumumab Revenue and Market Share by Type (2014-2019)
10.2 Global Panitumumab Market Forecast by Type (2019-2024)
10.3 100 mg/5 mL single-dose vials Revenue Growth Rate (2014-2024)
10.4 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2014-2024)
11 Global Panitumumab Market Segment by Application
11.1 Global Panitumumab Revenue Market Share by Application (2014-2019)
11.2 Panitumumab Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Panitumumab Market Size Forecast (2019-2024)
12.1 Global Panitumumab Market Size Forecast (2019-2024)
12.2 Global Panitumumab Market Forecast by Regions (2019-2024)
12.3 North America Panitumumab Revenue Market Forecast (2019-2024)
12.4 Europe Panitumumab Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Panitumumab Revenue Market Forecast (2019-2024)
12.6 South America Panitumumab Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Panitumumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Panitumumab Picture
Table Product Specifications of Panitumumab
Table Global Panitumumab and Revenue (Million USD) Market Split by Product Type
Figure Global Panitumumab Revenue Market Share by Types in 2018
Figure 100 mg/5 mL single-dose vials Picture
Figure 400 mg/20 mLsingle-dose vials Picture
Table Global Panitumumab Revenue (Million USD) by Application (2014-2024)
Figure Panitumumab Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Panitumumab Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Panitumumab Type and Applications
Table Amgen Panitumumab Revenue, Gross Margin and Market Share (2017-2018)
Table Global Panitumumab Revenue (Million USD) by Players (2014-2019)
Table Global Panitumumab Revenue Share by Players (2014-2019)
Figure Global Panitumumab Revenue Share by Players in 2017
Figure Global Panitumumab Revenue Share by Players in 2018
Figure Global Top 5 Players Panitumumab Revenue Market Share in 2018
Figure Global Top 10 Players Panitumumab Revenue Market Share in 2018
Figure Global Panitumumab Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Panitumumab Revenue (Million USD) by Regions (2014-2019)
Table Global Panitumumab Revenue Market Share by Regions (2014-2019)
Figure Global Panitumumab Revenue Market Share by Regions (2014-2019)
Figure Global Panitumumab Revenue Market Share by Regions in 2018
Figure North America Panitumumab Revenue and Growth Rate (2014-2019)
Figure Europe Panitumumab Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Panitumumab Revenue and Growth Rate (2014-2019)
Figure South America Panitumumab Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Panitumumab Revenue and Growth Rate (2014-2019)
Table North America Panitumumab Revenue by Countries (2014-2019)
Table North America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure North America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure North America Panitumumab Revenue Market Share by Countries in 2018
Figure USA Panitumumab Revenue and Growth Rate (2014-2019)
Figure Canada Panitumumab Revenue and Growth Rate (2014-2019)
Figure Mexico Panitumumab Revenue and Growth Rate (2014-2019)
Table Europe Panitumumab Revenue (Million USD) by Countries (2014-2019)
Figure Europe Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Europe Panitumumab Revenue Market Share by Countries in 2018
Figure Germany Panitumumab Revenue and Growth Rate (2014-2019)
Figure UK Panitumumab Revenue and Growth Rate (2014-2019)
Figure France Panitumumab Revenue and Growth Rate (2014-2019)
Figure Russia Panitumumab Revenue and Growth Rate (2014-2019)
Figure Italy Panitumumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Panitumumab Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Panitumumab Revenue Market Share by Countries in 2018
Figure China Panitumumab Revenue and Growth Rate (2014-2019)
Figure Japan Panitumumab Revenue and Growth Rate (2014-2019)
Figure Korea Panitumumab Revenue and Growth Rate (2014-2019)
Figure India Panitumumab Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Panitumumab Revenue and Growth Rate (2014-2019)
Table South America Panitumumab Revenue by Countries (2014-2019)
Table South America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure South America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure South America Panitumumab Revenue Market Share by Countries in 2018
Figure Brazil Panitumumab Revenue and Growth Rate (2014-2019)
Figure Argentina Panitumumab Revenue and Growth Rate (2014-2019)
Figure Colombia Panitumumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Panitumumab Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Panitumumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Panitumumab Revenue and Growth Rate (2014-2019)
Figure UAE Panitumumab Revenue and Growth Rate (2014-2019)
Figure Egypt Panitumumab Revenue and Growth Rate (2014-2019)
Figure Nigeria Panitumumab Revenue and Growth Rate (2014-2019)
Figure South Africa Panitumumab Revenue and Growth Rate (2014-2019)
Table Global Panitumumab Revenue (Million USD) by Type (2014-2019)
Table Global Panitumumab Revenue Share by Type (2014-2019)
Figure Global Panitumumab Revenue Share by Type (2014-2019)
Figure Global Panitumumab Revenue Share by Type in 2019
Table Global Panitumumab Revenue Forecast by Type (2019-2024)
Figure Global Panitumumab Market Share Forecast by Type (2019-2024)
Figure Global 100 mg/5 mL single-dose vials Revenue Growth Rate (2014-2019)
Figure Global 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2014-2019)
Table Global Panitumumab Revenue by Application (2014-2019)
Table Global Panitumumab Revenue Share by Application (2014-2019)
Figure Global Panitumumab Revenue Share by Application (2014-2019)
Figure Global Panitumumab Revenue Share by Application in 2019
Table Global Panitumumab Revenue Forecast by Application (2019-2024)
Figure Global Panitumumab Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Panitumumab Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Panitumumab Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Panitumumab Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Panitumumab Revenue Market Forecast (2019-2024)
Figure Europe Panitumumab Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Panitumumab Revenue Market Forecast (2019-2024)
Figure South America Panitumumab Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Panitumumab Revenue Market Forecast (2019-2024)
  • Global Asian Ginseng Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Sep-2019        Price: US 3480 Onwards        Pages: 119
    Panax ginseng, the ginseng, also known as Asian ginseng, Chinese ginseng, or Korean ginseng, is a species of plant whose root is the original source of ginseng. It is a perennial plant that grows in the mountains of Eastern Asia. Scope of the Report: The worldwide market for Asian Ginseng is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.......
  • Global Pharma Grade Calcium Phosphate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Sep-2019        Price: US 3480 Onwards        Pages: 115
    Calcium phosphate is a family of materials and minerals containing calcium ions (Ca2+) together with inorganic phosphate anions. Scope of the Report: The worldwide market for Pharma Grade Calcium Phosphate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pharma Grade Calcium Phosphate in global market, e......
  • Global Specialty Capsules Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    Specialty Capsule refers to capsule that developed from special kind of raw material. In this report, it can be divided into coffee Capsules, gelatin Capsules The global Specialty Capsules market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Specialty Capsules volume and value at global level, regional level and company level. From a global perspective, this report rep......
  • Global Prophy Paste Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    Prophy pastes for oral health treatments designed to be effective and kind on natural teeth and restorations. The global Prophy Paste market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Prophy Paste volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prophy Paste market size by analyzing histori......
  • Global Biological Drugs Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure. T......
  • Global Adult Meal Replacement Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    The global Adult Meal Replacement market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Adult Meal Replacement volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adult Meal Replacement market size by analyzing historical data and future prospect. Regionally, this report categorizes the production......
  • Global Oxycodone Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    The global Oxycodone market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Oxycodone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oxycodone market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and impo......
  • Global Oral Hypoglyceimic Agents (OHAs) Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin. At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market. The global Oral Hypoglyceimic Agents (OHAs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAG......
  • Global Veterinary/Animal Vaccines Market Professional Survey Report 2019
    Published: 17-Sep-2019        Price: US 3500 Onwards        Pages: 111
    The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology. In 2017, in terms of value, Europe is expected to account for the largest share of the global animal vaccines market, followed by North America. However, the Asia Pacific region is expected to register the highest growth during the forecast period. The global Veterinary/Animal Vaccines market was valued at xx mill......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs